$20.03▴ 3.57%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$-48.98MTTM operating cash
Pre-profit
It is still burning cash while pre-profit.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
+43.2%year over year
Strong
Revenue is growing strongly year over year.
Leverage
Lowdebt to assets
Strong
Very low debt relative to its asset base.
More coming: dilution / share-count creep.
✦ The read
PROCEPT BioRobotics Corporation is pre-profit. It is still burning cash while pre-profit. Revenue is growing strongly year over year. Very low debt relative to its asset base.
Key numbers
Valuation
EPS (TTM)$-1.71
TTM (trailing 12 months, through fiscal Q4 FY2025)
Profitability
Net margin-31.0%
TTM (trailing 12 months, through fiscal Q4 FY2025)
Size
Revenue (TTM)$308.05M
TTM (trailing 12 months, through fiscal Q4 FY2025)
Recent news
Sentiment · last 30 days16 articles
0 bullish0 neutral16 bearish
Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRCT
INVESTOR ALERT: RGRD Law Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead the Procept Class Action Lawsuit - PRCT
Signals and key numbers are from the fiscal Q4 FY2025 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.